Fact CheckerSign in

NCT05646680Completed

A Performance Study of (Opportunistic) Salpingectomy

Source: ClinicalTrials.gov · Last updated 29 Jan 2026

Brief summary (registry, in English)

The goal of this clinical trial is to test the quality of the performance of opportunistic salpingectomies in women scheduled for adnexectomy. The main questions it aims to answer are: * How many salpingectomies are incomplete? * Are there any factors related to incomplete resection? Could the investigators develop a instruction video to optimize the surgical technique? Participants planned for uni-or bilateral adnexectomy (removal of ovary and salpinx) will have their adnexectomy in two steps in the same surgical episode: first the salpingectomy (removal of the salpinx), then the oophorectomy (the removal of the ovary).

Status (registry)
Completed
Study type
Interventional
Enrollment
115 (actual)
First submitted
24 Nov 2022
Start date
9 Dec 2022
Primary completion date
12 Apr 2025
Lead sponsor
University Hospital, Ghent
NCT number
NCT05646680

What you commit to

  • Study type: Interventional
  • Participants enrolled: 115
  • From 9 Dec 2022 to the primary completion date, 12 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • radiotherapy in the pelvis in the medical history
  • Adnexectomy for gender transformation surgery if wish to preserve the ovarian tissue.
  • Surgery in two steps is not safe to perform

Other illness

  • \* Endometrial cancer or invasive cervical cancer
  • Pelvic Inflammatory Disease

Other

  • (partial) salpingectomy
  • Pregnancy

Who the study is looking for

  • Patients scheduled for uni- or bilateral adnexectomy. (may be in combination with hysterectomy) AND \* competent to act on itself
  • dutch speaking
  • signed informed consent

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Hospital
Coordinator of this site? Confirm its status
GhentBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.